CompanyDeals

Formosa Pharmaceuticals Strikes Licensing Deal with Cristália for Ocular Surgery Pain Treatment in Brazil

Company

Lonza Announces Factory Closures in the US and China Amid Global Network Optimization

CompanyPolicy / Regulatory

China-Based Biotechs Respond to US House Bill Limiting Federal Funding for ‘Concerning’ Companies

CompanyDrug

Eisai’s Alzheimer’s Drug Leqembi Earns Marketing Approval in China

CompanyDeals

Wuxi National Hi-Tech District Welcomes Synthetic Biology Industrial Park and East China’s First R&D Center

CompanyDeals

Kingmed Diagnostics and MegaRobo Technologies Join Forces to Pioneer Smart Medical Laboratories

CompanyDrug

Henlius Biotech Ships First International Batch of HanSiZhuang for Cancer Treatment to Indonesia

CompanyDrug

Shanghai Fosun Pharmaceutical Receives NMPA Approval for Phase II Study of FCN-338 for Light Chain Amyloidosis

CompanyDeals

MSD Partners with Variational AI to Harness Generative AI for Drug Discovery

CompanyDrug

Gan & Lee Pharmaceuticals Receives Bolivian Approval for Insulin Aspart, Expanding Access to Rapid-Acting Insulin

Policy / Regulatory

China’s NHC Designates 100 Areas as National Demonstration Zones for Integrated Medical and Elderly Care

CompanyDrug

Roche Commences Phase II Trial of Repare Therapeutics’ ATR Inhibitor, Camonsertib, in Solid Tumors